GlassScriptPhysician profile
Ross S Pacini
NPI 1467636928
$1,663.17
in general payments reported to CMS, 2019-2025
24 companies · $76.23 in 2025
The $76.23 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $355 · 2020: $442 · 2021: $614 · 2022: $98.23 · 2023: $59.41 · 2024: $17.58 · 2025: $76.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $153.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $201.60 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $199.67 | 2019-2025 | Camzyos |
| Medtronic, INC. | $162.70 | 2021-2025 | Corevalve Evolut R |
| Janssen Pharmaceuticals, INC | $153.86 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $128.91 | 2019-2025 | |
| Boston Scientific Corporation | $122.12 | 2020-2021 | |
| Bard Peripheral Vascular, INC. | $107.95 | 2021 | |
| Amgen INC. | $105.00 | 2020-2025 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $104.71 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $53.71 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $43.74 | 2021-2023 | Verquvo |
| Pfizer INC. | $41.36 | 2020-2021 | |
| Chiesi USA, INC. | $38.32 | 2021 | |
| Altathera Pharmaceuticals LLC | $24.80 | 2022 | |
| Amryt Pharma Holdings LTD | $22.13 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Artivion, INC. | $21.49 | 2020 | |
| Bardy Diagnostics, INC. | $20.66 | 2021 | |
| Tactile Systems Technology INC | $19.39 | 2021 | |
| Angiodynamics, INC. | $18.73 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $17.78 | 2019 | |
| Lantheus Medical Imaging, INC. | $16.22 | 2019 | |
| Sanofi-Aventis U.S. LLC | $16.16 | 2019 | |
| Medtronic Vascular, INC. | $15.95 | 2020 | |
| Hitachi Healthcare Americas Corp. | $6.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ross Pacini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.